Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2023 at "Advanced healthcare materials"
DOI: 10.1002/adhm.202300670
Abstract: Programmed death ligand-1 (PD-L1) and donor antigens are critical for donor immature dendritic cells (DCs) targeting donor-specific T cells to induce transplant tolerance. This study aimed to clarify whether DC-derived exosomes (DEX) with donor antigens…
read more here.
Keywords:
inhibitory signals;
specific cells;
donor specific;
donor ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancer Cytopathology"
DOI: 10.1002/cncy.21987
Abstract: Immune checkpoint inhibitors targeting the programmed cell death 1 (PD‐1) receptor and its ligand, programmed death ligand 1 (PD‐L1), have emerged as a therapeutic approach for patients with non–small cell lung carcinoma (NSCLC). PD‐L1 expression,…
read more here.
Keywords:
programmed death;
cell;
cytology;
death ligand ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.23900
Abstract: Pembrolizumab was recently approved as a first line agent for metastatic NSCLC in patients with high programmed death‐ligand 1 (PD‐L1) expression.
read more here.
Keywords:
ligand expression;
programmed death;
death ligand;
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2022 at "Diagnostic Cytopathology"
DOI: 10.1002/dc.24955
Abstract: In this era of personalized medicine, targeted immunotherapies like immune checkpoint inhibitors (ICI) blocking the programmed death‐1 (PD‐1)/program death ligand‐1 (PD‐L1) axis have become an integral part of treating advanced stage non‐small cell lung carcinoma…
read more here.
Keywords:
death ligand;
lung;
program death;
cytology ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Methods in molecular biology"
DOI: 10.1007/978-1-0716-1278-1_4
Abstract: Programmed cell death 1 (PD-1) plays an important role in subsiding immune responses, in promoting self-tolerance through suppressing the activity of T-cells, and in promoting differentiation of regulatory T-cells. One of its ligands, programmed cell…
read more here.
Keywords:
cancer;
death ligand;
programmed cell;
cell death ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-020-02654-0
Abstract: Dendritic cell (DC)-based vaccines are recognized as a promising immunotherapeutic strategy against cancer; however, the efficacy of immunotherapy with DCs is controlled via immune checkpoints, such as programmed death-ligand 1 (PD-L1). PD-L1 expressed on DC…
read more here.
Keywords:
programmed death;
dendritic cell;
death ligand;
myeloma ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2021 at "International Journal of Clinical Oncology"
DOI: 10.1007/s10147-021-01993-x
Abstract: Programmed death-ligand 1 (PD-L1) positivity is associated with poor prognosis in renal cell carcinoma (RCC). Because the prognostic impact and effect of confounding factors are less known, we investigated the prognostic significance of PD-L1 expression…
read more here.
Keywords:
status;
renal cell;
cell carcinoma;
japanese patients ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2018 at "Clinical and Translational Oncology"
DOI: 10.1007/s12094-018-1970-9
Abstract: IntroductionProgrammed death-ligand 1 (PD-L1) is reportedly expressed in colorectal tumors. However, the prognostic role of PD-L1 in colorectal cancer (CRC) remains controversial. Therefore, we performed a meta-analysis to investigate the clinicopathological and prognostic impact of…
read more here.
Keywords:
colorectal cancer;
death ligand;
expression;
cancer ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "European journal of cancer"
DOI: 10.1016/j.ejca.2018.11.007
Abstract: BACKGROUND Recently, the Food and Drug Administration (FDA)/European Medicines Agency (EMA) restricted first-line use of atezolizumab and pembrolizumab in patients with metastasised urothelial carcinoma by defining distinct programmed cell death ligand-1 cut-offs. We analysed the…
read more here.
Keywords:
first line;
atezolizumab pembrolizumab;
death ligand;
programmed cell ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of autoimmunity"
DOI: 10.1016/j.jaut.2019.102362
Abstract: Dendritic cells (DCs) play key roles in regulating T cell proliferation and differentiation, and epigenetic modification involves in this process. In the periphery, programmed death ligand-1 (PD-L1) expressed on antigen-presenting cells interacts with programmed death-1…
read more here.
Keywords:
dna;
programmed death;
death ligand;
dna demethylation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Journal of Neuroimmunology"
DOI: 10.1016/j.jneuroim.2018.09.012
Abstract: We investigated the expression patterns of programmed cell death-ligand 1 (PD-L1) in the skeletal muscle of 15 patients with myasthenia gravis (MG). In 11 of the patients, immunohistochemistry confirmed the localization of PD-L1 in the…
read more here.
Keywords:
muscle;
death ligand;
programmed cell;
expression ... See more keywords